Beck Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,405
Closed -$1.75M 121
2022
Q4
$1.75M Buy
+3,405
New +$1.73M 0.74% 63
2020
Q1
Sell
-715
Closed -$216K 77
2019
Q4
$216K Buy
+715
New +$197K 0.11% 103

Other funds holding ELV

Beck Capital Management's ELV Position: Q1 2023 in Review

Beck Capital Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 3,405 shares — an estimated $1.75M sold.

Beck Capital Management first reported a position in ELV in Q4 2019 and held it in 2 quarters. The position peaked at $1.75M in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Beck Capital Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Beck Capital Management sold 3,405 Elevance Health shares in Q1 2023, an estimated $1.75M.
  • Beck Capital Management first reported a position in Elevance Health in Q4 2019 and held it in 2 quarters.
  • Beck Capital Management's Elevance Health position peaked at $1.75M in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Beck Capital Management's 13F filing for Q1 2023, filed 15 May 2023.